Who
Timothy R. Pearson
Director
Company insider
Files Form 4 as: Director, Korro Bio; Director, Crescent Biopharma; Director, Ra Pharmaceuticals; Exec. VP, CFO, Tesaro; EVP & Chief Financial Officer, Catalyst Health Solutions.
In numbers
- Trades disclosed
- 54
- Buys
- 1
- Sells
- 2
- Bought
- $25K
- Sold
- $398K
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 15 Sep 2011
- Last trade
- 10 Jun 2026
- Last filed
- 11 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 11 Jun 2026 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —14,677 at $0.00 | filing |
| 10 Jun 2026filed 11 Jun 2026 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —14,677 at $0.00 | filing |
| 11 Jun 2025filed 12 Jun 2025 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —6,010 at $0.00 | filing |
| 11 Jun 2024filed 12 Jun 2024 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —5,190 at $0.00 | filing |
| 1 May 2024filed 1 May 2024 | CBIO Crescent Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 3 Nov 2023filed 7 Nov 2023 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 19 May 2023filed 22 May 2023 | CBIO Crescent Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 11 Nov 2022filed 14 Nov 2022 | CBIO Crescent BiopharmaBiotechnology | SEC FORM 4 Bought | $25K19,400 at $1.29 | filing |
| 18 May 2022filed 20 May 2022 | CBIO Crescent Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,000 at $0.00 | filing |
| 18 May 2021filed 27 May 2021 | CBIO Crescent BiopharmaBiotechnology | SEC FORM 4 Code A | —5,250 at $0.00 | filing |
| 18 May 2021filed 27 May 2021 | CBIO Crescent Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,500 at $0.00 | filing |
| 22 May 2020filed 27 May 2020 | CBIO Crescent Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,000 at $0.00 | filing |
| 2 Apr 2020filed 3 Apr 2020 | Ra Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —22,857 at $0.00 | filing |
| 2 Apr 2020filed 3 Apr 2020 | Ra Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —15,000 at $0.00 | filing |
| 2 Apr 2020filed 3 Apr 2020 | Ra Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —15,000 at $0.00 | filing |
| 2 Apr 2020filed 3 Apr 2020 | Ra Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —15,000 at $0.00 | filing |
| 11 Jun 2019filed 13 Jun 2019 | Ra Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 17 May 2019filed 21 May 2019 | CBIO Crescent Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,000 at $0.00 | filing |
| 22 Jan 2019filed 22 Jan 2019 | Tesarooption or derivative | SEC FORM 4 Code D | —8,750 | filing |
| 22 Jan 2019filed 22 Jan 2019 | Tesarooption or derivative | SEC FORM 4 Code D | —4,447 | filing |
News
No headline names them, or the companies they trade most, lately.